Article

FDA Advises Against High-Dose Acetaminophen Combinations

The Food and Drug Administration has advised physicians to discontinue prescribing medications that contain more than 325 mg per dose of acetaminophen, citing risks to the liver.

The Food and Drug Administration has advised physicians to discontinue prescribing medications that contain more than 325 mg per dose of acetaminophen, citing risks to the liver.

There is no good evidence for efficacy above this dose, says the Safety Alert from the Agency, and severe liver injury has occurred in patients who took more than the recommended dose over 24 hours, combined different drugs containing acetaminophen, or drank alcohol while taking the drug.

Although manufacturers of over-the-counter drugs have limited acetaminophen doses to 325 mg, some prescription combinations continue to contain larger doses. The FDA says it is considering withdrawing approval for these combinations.

Related Videos
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
© 2024 MJH Life Sciences

All rights reserved.